The global hemodialysis market size was valued at USD 37.44 billion in 2025 and is projected to grow from USD 39.29 billion in 2026 to USD 57.84 billion by 2034 at a CAGR of 4.95% during the forecast period 2026-2034. North America dominated the hemodialysis market with a market share of 38.2% in 2025.
Hemodialysis is a medical treatment that uses a dialysis machine and a special filter called a dialyzer to remove waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to function properly. During the treatment, blood is circulated from the body through the dialyzer, where it is cleaned, and then returned to the body. Hemodialysis is commonly used for people with advanced or end-stage kidney disease and is typically performed several times a week in a dialysis center or, in some cases, at home.
Download a Free Sample To learn more about this report,
The hemodialysis market is increasingly shifting toward home-based care, supported by policy changes and advances in dialysis technology. In the U.S., CMS expanded Medicare payment for home dialysis for eligible patients with acute kidney injury (AKI) in 2025, giving patients more treatment flexibility. CMS also updated guidance in 2025 for preconfigured hemodialysis systems designed for both home and in-center use, highlighting the growing role of simplified equipment. However, in-center treatment remains dominant: CMS data show that about 83% of dialysis patients were receiving in-center hemodialysis, while home hemodialysis accounted for roughly 4% in recent reporting years. Rising kidney disease prevalence is another major demand driver, with the CDC estimating that 14% of U.S. adults, or around 37 million people, had chronic kidney disease in 2026. These trends point toward greater adoption of home dialysis, connected devices, and patient-centered treatment models.
The growing burden of chronic kidney disease (CKD) is a major driver of the hemodialysis market. According to the CDC's 2026 data, around 37 million U.S. adults, or 14%, have CKD, while 38% of adults with diabetes and 21% of adults with high blood pressure are estimated to have CKD. The aging population also supports demand, as CKD affects 34% of adults aged 65 and older, compared with 13% of those aged 45–64. In addition, diabetes remains a key risk factor for kidney failure, while increasing awareness and screening are helping identify patients earlier. As CKD progresses to kidney failure, the need for regular dialysis treatment creates sustained demand for hemodialysis equipment, consumables, and services.
The hemodialysis market faces restraints from treatment-related complications, infection risks, and the demanding nature of long-term therapy. The CDC notes that infections are common among dialysis patients and can become serious, particularly when central venous catheters are used for vascular access. CMS data for 2023 showed that 17.9% of U.S. hemodialysis patient-months involved long-term catheter use, highlighting an ongoing clinical challenge. Hemodialysis also requires regular, time-intensive treatments, which can affect patients' daily routines and reduce treatment flexibility. In addition, maintaining dialysis infrastructure and providing continuous care require substantial healthcare resources. These challenges, along with vascular-access complications and the need for strict infection-control practices, can limit wider adoption of hemodialysis, especially in healthcare systems with limited resources.
The hemodialysis market has strong opportunities in home dialysis, remote monitoring, and easier-to-use dialysis systems. Recent CMS data show that home hemodialysis represented about 4% of dialysis patients, compared with roughly 83% receiving in-center hemodialysis, indicating significant room for expansion. Policy support is also improving: CMS expanded Medicare payment for home dialysis for eligible patients with acute kidney injury in 2025. In addition, CMS expects to pay around $6 billion to approximately 7,600 U.S. ESRD facilities in 2026, supporting continued investment in dialysis services and infrastructure. Manufacturers can benefit by developing compact machines, connected monitoring tools, and technologies that simplify treatment at home. These developments could improve patient flexibility while creating new opportunities for equipment and service providers.
The hemodialysis market faces challenges related to patient safety, infection control, and the complexity of long-term treatment. In the U.S., more than 450,000 people regularly receive hemodialysis across roughly 6,800 facilities, creating a large and demanding care network. Infection remains a major concern because patients require repeated vascular access. CDC data show that dialysis patients are about 100 times more likely to develop a staphylococcal bloodstream infection than adults who are not on dialysis. Antibiotic resistance adds further pressure, with at least 30% of U.S. maintenance hemodialysis patients receiving IV antibiotics at least once a year. Reducing catheter-related infections, improving vascular access, maintaining strict infection-control standards, and managing complex patient needs remain key challenges for providers.
Request Customizationto receive a tailored report.
The Conventional segment is the leading category in the By Type segmentation, accounting for a 72.5% market share and growing at a 5.94% CAGR, while the Nocturnal segment is the fastest-growing, with a 7.64% CAGR. Conventional hemodialysis remains important because it is a widely established treatment approach supported by existing clinical infrastructure and healthcare services. Its large share reflects continued demand for regular dialysis among patients who require ongoing kidney replacement therapy. At the same time, daily and nocturnal dialysis are gaining attention as patients and healthcare providers seek treatment options that can offer greater flexibility and potentially fit better into individual lifestyles.
In the By Product segmentation, Service is the leading segment with a 39.6% market share and a 6.58% CAGR, while Consumable is the fastest-growing segment, recording a 6.79% CAGR. Services play a central role in the hemodialysis market because patients require regular treatment, professional supervision, equipment management, and ongoing clinical support. The strong position of this segment reflects the continuous nature of dialysis care and the importance of reliable treatment delivery. Consumables also have a significant role because hemodialysis procedures depend on products that are regularly used during treatment.
Within the By End User segmentation, hospital based dialysis leads the market with an 84.6% market share and a 6.08% CAGR, while home dialysis is the fastest-growing segment, with an 8.21% CAGR. Hospital-based dialysis remains the dominant end-user category because many patients depend on established healthcare facilities for regular treatment, professional monitoring, and access to specialized medical staff and equipment. Its leading position highlights the continued importance of clinical settings in delivering hemodialysis services. However, the faster growth of home dialysis indicates increasing interest in treatment models that provide greater convenience and flexibility.
Speak to an Analystto discuss market opportunities.
North America is the dominant region in the hemodialysis market, holding a 38.2% market share with a market value of $14.3 billion and a 6.18% CAGR. The region's leading position is supported by established healthcare infrastructure, widespread access to specialized kidney care, and strong demand for regular dialysis services. A high burden of chronic kidney disease and an aging population continue to support the need for hemodialysis treatment. The region also benefits from the availability of advanced dialysis equipment, professional care services, and well-developed treatment facilities.
The United States plays a central role in the North American hemodialysis market because of its established dialysis care network and strong demand for kidney replacement therapy. Consumer demand is supported by the large number of patients who require regular dialysis and by the availability of specialized treatment centers. The country is also seeing growing interest in home dialysis, as patients and healthcare providers look for more flexible approaches to treatment. Technological development is another important factor, with continued attention to connected devices, remote monitoring, and systems that can simplify dialysis management.
Canada contributes to the North American hemodialysis market through its established healthcare system and ongoing demand for kidney disease treatment. The country's market is supported by the need for regular dialysis among patients with advanced kidney disease, while an aging population and the growing burden of chronic conditions continue to create healthcare demand. Treatment accessibility across a geographically large country is an important consideration, particularly for patients living far from major healthcare centers. This has encouraged interest in home dialysis and other approaches that can reduce the need for frequent travel to treatment facilities.
Europe is the second-largest regional market by share, accounting for 30.4% and generating a market value of $11.38 billion. At the same time, Europe is the fastest-growing region in the provided analysis, with a 7.12% CAGR. The region's growth is supported by established healthcare systems, rising demand for kidney disease management, and increasing attention to advanced and patient-focused dialysis care. European countries have well-developed medical infrastructure and access to specialized treatment services, creating a strong foundation for hemodialysis adoption.
Germany is an important country in the European hemodialysis market, supported by its developed healthcare infrastructure and access to specialized medical services. Demand for hemodialysis is influenced by the need to manage advanced kidney disease and provide long-term treatment for patients who require regular dialysis. The country's established healthcare system supports the availability of dialysis centers, professional medical staff, and treatment technologies. There is also growing attention to improving patient comfort and treatment flexibility, which can encourage interest in home-based dialysis and other patient-centered care models.
The United Kingdom is a significant contributor to the European hemodialysis market, with demand supported by its organized healthcare system and established renal care services. Patients requiring long-term kidney replacement therapy create sustained demand for dialysis facilities, equipment, and related services. The country's healthcare environment also places emphasis on improving access to treatment and supporting care models that are convenient for patients. Home dialysis is an area of interest because it can provide greater flexibility for suitable patients and reduce dependence on frequent visits to treatment centers.
Asia Pacific holds a 22.6% market share in the hemodialysis market, with a market value of $8.46 billion and a 6.85% CAGR. The region is supported by increasing healthcare needs, a growing burden of chronic diseases, and rising awareness of kidney health and treatment options. Demand is influenced by the expanding patient population requiring renal replacement therapy and the gradual development of healthcare infrastructure across several countries. Japan and China are important markets in the region, with their healthcare systems contributing to overall demand for dialysis treatment.
Japan is an important country in the Asia Pacific hemodialysis market, supported by an advanced healthcare system and established renal treatment infrastructure. The country's aging population creates ongoing demand for chronic disease management and long-term kidney care. Patients who require regular dialysis benefit from access to specialized treatment facilities and experienced healthcare professionals. Japan is also known for its strong technology sector, which can support the development and adoption of advanced medical devices and dialysis technologies. Healthcare providers continue to focus on improving treatment quality, patient safety, and efficiency.
China represents an important growth market within the Asia Pacific hemodialysis market, supported by a large population and increasing healthcare needs. Demand for dialysis treatment is influenced by the growing recognition of chronic kidney disease and the need to expand access to renal care. The development of healthcare infrastructure and greater availability of specialized treatment facilities are important factors shaping the market. In addition, improvements in medical technology and increasing healthcare investment can support wider access to dialysis equipment and services.
Latin America accounts for a 5.1% market share in the hemodialysis market, with a market value of $1.91 billion and a 5.74% CAGR. The region's market development is supported by increasing healthcare needs and demand for renal replacement therapy. However, access to specialized dialysis services can vary between countries and locations, creating differences in treatment availability and healthcare infrastructure. Brazil is an important market in the region and contributes significantly to demand for dialysis care. The development of healthcare facilities, greater awareness of kidney disease, and efforts to improve access to treatment can support future market expansion.
Brazil is a key country in the Latin American hemodialysis market, supported by its large population and ongoing need for kidney disease treatment. Demand for hemodialysis is linked to the need for long-term renal replacement therapy and the growing importance of managing chronic health conditions. The country's healthcare system includes dialysis services that support patients requiring regular treatment, while continued development of medical infrastructure can help improve access. Differences in healthcare availability between urban and less-served areas remain an important consideration for market development.
The Middle East and Africa region represents 3.7% of the hemodialysis market, with a market value of $1.39 billion and a 5.29% CAGR. The region's market is influenced by the need to improve access to kidney care and expand dialysis infrastructure. Demand for hemodialysis is supported by the presence of chronic diseases and the growing need for long-term treatment services. However, healthcare infrastructure and access to specialized dialysis facilities can vary considerably across countries. The UAE is an important market within the region, supported by healthcare development and investment in modern medical services.
The UAE (United Arab Emirates) is an important market within the Middle East and Africa Hemodialysis Market, supported by investment in healthcare infrastructure and the development of modern medical services. Demand for dialysis treatment is influenced by the need to manage chronic kidney disease and provide ongoing care for patients requiring renal replacement therapy. The country has continued to develop specialized healthcare facilities and advanced medical services, supporting access to dialysis treatment. Growing interest in healthcare technology can also create opportunities for modern dialysis equipment, monitoring solutions, and improved treatment delivery.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a Healthcare Lead with over 7 years of industry experience, specializing in Healthcare IT. She provides comprehensive market insights on digital health, electronic medical records, telehealth, and healthcare analytics. Debashree’s research supports organizations in adopting technology-driven healthcare solutions, improving patient care, and achieving operational efficiency in a rapidly transforming healthcare ecosystem.
We are featured on:
sales@straitsresearch.com